GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Medartis Holding AG (XSWX:MED) » Definitions » Price-to-Owner-Earnings

Medartis Holding AG (XSWX:MED) Price-to-Owner-Earnings : 59.02 (As of May. 14, 2024)


View and export this data going back to 2018. Start your Free Trial

What is Medartis Holding AG Price-to-Owner-Earnings?

As of today (2024-05-14), Medartis Holding AG's share price is CHF77.90. Medartis Holding AG's Owner Earnings per Share (TTM) ended in Dec. 2023 was CHF1.32. It's Price-to-Owner-Earnings for today is 59.02.


The historical rank and industry rank for Medartis Holding AG's Price-to-Owner-Earnings or its related term are showing as below:

XSWX:MED' s Price-to-Owner-Earnings Range Over the Past 10 Years
Min: 52.34   Med: 174.37   Max: 1358.33
Current: 58.84

During the past 10 years, the highest Price-to-Owner-Earnings of Medartis Holding AG was 1358.33. The lowest was 52.34. And the median was 174.37.


XSWX:MED's Price-to-Owner-Earnings is ranked worse than
70.29% of 276 companies
in the Medical Devices & Instruments industry
Industry Median: 32.745 vs XSWX:MED: 58.84

As of today (2024-05-14), Medartis Holding AG's share price is CHF77.90. Medartis Holding AG's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Dec. 2023 was CHF0.05. Therefore, Medartis Holding AG's PE Ratio for today is 1,558.00.

As of today (2024-05-14), Medartis Holding AG's share price is CHF77.90. Medartis Holding AG's EPS without NRI for the trailing twelve months (TTM) ended in was CHF0.05. Therefore, Medartis Holding AG's PE Ratio without NRI for today is 1,558.00.

During the past 10 years, Medartis Holding AG's highest PE Ratio without NRI was 1788.00. The lowest was 99.50. And the median was 215.56.


Medartis Holding AG Price-to-Owner-Earnings Historical Data

The historical data trend for Medartis Holding AG's Price-to-Owner-Earnings can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Medartis Holding AG Price-to-Owner-Earnings Chart

Medartis Holding AG Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Price-to-Owner-Earnings
Get a 7-Day Free Trial Premium Member Only Premium Member Only - 484.38 183.38 - 63.44

Medartis Holding AG Semi-Annual Data
Dec15 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23
Price-to-Owner-Earnings Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 183.38 - - - 63.44

Competitive Comparison of Medartis Holding AG's Price-to-Owner-Earnings

For the Medical Devices subindustry, Medartis Holding AG's Price-to-Owner-Earnings, along with its competitors' market caps and Price-to-Owner-Earnings data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Medartis Holding AG's Price-to-Owner-Earnings Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Medartis Holding AG's Price-to-Owner-Earnings distribution charts can be found below:

* The bar in red indicates where Medartis Holding AG's Price-to-Owner-Earnings falls into.



Medartis Holding AG Price-to-Owner-Earnings Calculation

In 1986 Berkshire Hathaway Shareholder Letter, Warren Buffett defined owner earnings as follows:

"These represent (a) reported earnings plus (b) depreciation, depletion, amortization, and certain other non-cash charges...less (c) the average annual amount of capitalized expenditures for plant and equipment, etc. that the business requires to fully maintain its long-term competitive position and its unit volume. (If the business requires additional working capital to maintain its competitive position and unit volume, the increment also should be included in (c))...Our owner-earnings equation does not yield the deceptively precise figures provided by GAAP, since (c) must be a guess - and one sometimes very difficult to make. Despite this problem, we consider the owner earnings figure, not the GAAP figure, to be the relevant item for valuation purposes - both for investors in buying stocks and for managers in buying entire businesses...All of this points up the absurdity of the 'cash flow' numbers that are often set forth in Wall Street reports. These numbers routinely include (a) plus (b) - but do not subtract (c)."

Medartis Holding AG's Price-to-Owner-Earnings for today is calculated as

Price-to-Owner-Earnings=Share Price/Owner Earnings per Share (TTM)
=77.90/1.32
=59.02

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Medartis Holding AG  (XSWX:MED) Price-to-Owner-Earnings Explanation

For how to get Owner Earnings per Share (TTM), please click.


Medartis Holding AG Price-to-Owner-Earnings Related Terms

Thank you for viewing the detailed overview of Medartis Holding AG's Price-to-Owner-Earnings provided by GuruFocus.com. Please click on the following links to see related term pages.


Medartis Holding AG (XSWX:MED) Business Description

Traded in Other Exchanges
Address
Hochbergerstrasse 60E, Basel, CHE, 4057
Medartis Holding AG is a medical device company. The company's product profile is divided into APTUS products and MODUS products. APTUS includes products for Hand, Wrist, Elbow, Shoulder, and Foot. MODUS comprises products for Cranium, Midface, and mandible. Geographically, it derives majority of the revenue from EMEA and also has a presence in APAC; LATAM and North America.